Cross Country Healthcare (CCRN) AI Stock Analysis

• Market Cap: $431.15M
• Dividend Yield: N/A
• Average Volume (3M): 332.01K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.02
• Revenue Growth: -24.30%
• EPS Growth: -210.27%
• Country: US
• Employees: 9,605
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): -0.01
• Shares Outstanding: 32,761,993
• 10 Day Avg. Volume: 489,338
• 30 Day Avg. Volume: 332,009
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 0.80
• Enterprise Value/Revenue: 0.29
• Enterprise Value/Gross Profit: 1.46
• Enterprise Value/Ebitda: 26.98
• 1Y Price Target: $15.56
• Price Target Upside: 18.60% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 5

• Rating: 46 Neutral
• Price Target: $12.50 ▼(-4.73% Downside)

Cross Country Healthcare's stock score is primarily impacted by its financial performance challenges, including declining revenue and profitability. The technical analysis indicates a bearish trend, and the valuation is unattractive due to a negative P/E ratio. The absence of earnings call data and corporate events leaves these areas unaddressed.

Positive Factors

Strong Balance Sheet

A strong balance sheet with low leverage reduces financial risk and provides stability, allowing the company to weather economic fluctuations and invest in growth opportunities.

Cash Generation Ability

Despite challenges, the ability to generate cash relative to net income suggests potential for reinvestment in the business and meeting financial obligations, supporting long-term operations.

Market Position

As a leading provider in healthcare staffing, CCRN benefits from strong demand for its services, which can drive consistent revenue and provide a competitive edge in a growing market.

Negative Factors

Declining Revenue

Declining revenue growth indicates challenges in maintaining market share or pricing power, which can impact long-term profitability and competitive positioning if not addressed.

Profitability Challenges

Sustained net losses and low margins highlight operational inefficiencies, which can erode shareholder value and limit the company's ability to invest in future growth.

Cash Flow Management

Poor cash flow management can strain liquidity and hinder the company's ability to fund operations or invest in strategic initiatives, impacting long-term sustainability.

Cross Country Healthcare Business Overview & Revenue Model

Company Description

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.

How the Company Makes Money

Cross Country Healthcare generates revenue primarily through its staffing services, which include travel nurse placements, per diem staffing, and allied health staffing. The company charges healthcare facilities a fee for each healthcare professional placed, often based on a markup on the hourly wage paid to the staff. Additionally, CCRN earns revenue through managed services provider (MSP) solutions and other workforce management services that streamline staffing processes for healthcare organizations. Significant partnerships with hospitals, healthcare systems, and other entities enhance its service offerings and contribute to consistent demand for its staffing solutions, ultimately driving its earnings.

Cross Country Healthcare Financial Statement Overview

Summary

Cross Country Healthcare is facing challenges in revenue growth and profitability, with declining margins and negative net income. The balance sheet is strong with low leverage, but the company needs to enhance its return on equity. Cash flow management is concerning, with significant declines in free cash flow. Overall, the company needs to focus on improving operational efficiency and cash flow generation.

Income Statement

Cross Country Healthcare's income statement shows a declining trend in revenue with a negative revenue growth rate of -5.22% TTM. The gross profit margin has decreased from previous years, and the company is currently operating at a net loss, with a net profit margin of -0.91% TTM. The EBIT and EBITDA margins are also low, indicating challenges in operational efficiency. The company needs to address these issues to improve profitability.

Balance Sheet

The balance sheet reflects a strong equity position with a low debt-to-equity ratio of 0.0067 TTM, indicating low leverage and reduced financial risk. However, the return on equity is negative at -1.99% TTM, highlighting inefficiencies in generating returns for shareholders. The equity ratio is stable, suggesting a solid capital structure, but the company needs to improve its profitability to enhance shareholder value.

Cash Flow

Cash flow analysis reveals a significant decline in free cash flow growth at -69.39% TTM, which is concerning. The operating cash flow to net income ratio is 0.43, indicating that operating cash flows are not fully covering net income. The free cash flow to net income ratio is relatively high at 0.82, suggesting some ability to generate cash relative to net income, but overall cash flow management needs improvement.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.19B	1.34B	2.02B	2.81B	1.68B	836.42M
Gross Profit	236.47M	274.25M	450.41M	627.69M	375.00M	202.73M
EBITDA	12.81M	3.99M	129.34M	285.14M	152.35M	2.41M
Net Income	-8.35M	-14.56M	72.63M	188.46M	132.00M	-12.14M
Balance Sheet
Total Assets	553.82M	589.25M	679.32M	947.84M	732.81M	356.97M
Cash, Cash Equivalents and Short-Term Investments	81.19M	81.63M	17.09M	3.60M	1.04M	1.60M
Total Debt	2.77M	3.87M	5.27M	157.75M	195.49M	73.15M
Total Liabilities	141.58M	170.29M	205.92M	490.62M	435.28M	202.06M
Stockholders Equity	412.24M	418.96M	473.39M	457.22M	297.53M	154.38M
Cash Flow
Free Cash Flow	34.09M	111.40M	234.52M	125.26M	-92.79M	22.59M
Operating Cash Flow	41.60M	120.12M	248.50M	134.05M	-85.62M	27.20M
Investing Cash Flow	-7.51M	-8.71M	-13.78M	-43.87M	-34.05M	-4.62M
Financing Cash Flow	-22.48M	-46.85M	-221.24M	-87.60M	119.09M	-22.01M

Cross Country Healthcare Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 13.12
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCRN, the sentiment is Negative. The current price of 13.12 is below the 20-day moving average (MA) of 13.43, below the 50-day MA of 13.16, and below the 200-day MA of 14.96, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 47.85 is Neutral, neither overbought nor oversold. The STOCH value of 61.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CCRN.

Cross Country Healthcare Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PNTG	72 Outperform	841.93M	31.15	8.56%	―	30.58%	24.86%
HCSG	68 Neutral	1.13B	109.96	2.27%	―	5.17%	-65.33%
AVAH	59 Neutral	1.69B	107.45	-154.73%	―	11.53%	0.00%
AMN	54 Neutral	728.54M	-2.45	-49.02%	―	-14.33%	-398.68%
CCRN	46 Neutral	$431.15M	―	-1.96%	―	-24.30%	-210.27%
MODVQ	40 Underperform	3.88M	-0.02	523.15%	―	-0.70%	-2.38%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Cross Country Healthcare Corporate Events

Cross Country Healthcare Extends Merger Agreement Deadline

On September 3, 2025, Cross Country Healthcare announced an extension of the merger agreement end date with Aya Holdings II Inc. from September 3, 2025, to December 3, 2025. The merger, subject to regulatory approvals and customary conditions, is anticipated to close in the fourth quarter of 2025, with both companies having complied with the FTC’s request for additional information.

The most recent analyst rating on (CCRN) stock is a Hold with a $13.00 price target. To see the full list of analyst forecasts on Cross Country Healthcare stock, see the CCRN Stock Forecast page.

Cross Country Healthcare Reports Q2 2025 Financial Results

Cross Country Healthcare announced its second quarter 2025 financial results, reporting a revenue of $274.1 million, a 19% decrease year-over-year. Despite a net loss of $6.7 million, the company highlighted strong performance in its Homecare and Physician Staffing segments, with a 30% revenue growth in Homecare Staffing and a 3% increase in Physician Staffing. The company maintains a healthy balance sheet with $81 million in cash and no debt, and it continues to invest in its operations while anticipating a merger with Aya Healthcare in the fourth quarter of 2025.

The most recent analyst rating on (CCRN) stock is a Hold with a $18.61 price target. To see the full list of analyst forecasts on Cross Country Healthcare stock, see the CCRN Stock Forecast page.